Previous 10 | Next 10 |
Quest Diagnostics Incorporated (DGX) Q4 2022 Earnings Conference Call February 2, 2023 8:30 am ET Company Participants Jim Davis - President, Chief Executive Officer Sam Samad - Executive Vice President, Chief Financial Officer Shawn Bevec - Vice President, Investor Re...
Despite reporting better than expected Q4 2022 financials, Quest Diagnostics ( NYSE: DGX ) shed ~2% in the morning hours Thursday as the company set its 2023 revenue outlook below consensus amid falling revenue linked to COVID-19 testing. "COVID-19 testing revenues declined as...
Quest Diagnostics press release ( NYSE: DGX ): Q4 Non-GAAP EPS of $1.98 beats by $0.08 . Revenue of $2.33B (-15.0% Y/Y) beats by $70M . FY2023 reported diluted EPS expected to be between $7.61 and $8.21; and adjusted diluted EPS expected to be between $8.40 and $9.00 v...
QUEST DIAGNOSTICS REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS; PROVIDES GUIDANCE FOR FULL YEAR 2023 PR Newswire Fourth quarter revenues of $2.33 billion , down 15.0% from 2021 Fourth quarter reported diluted earnings per share ("EPS") of $0.87 , dow...
Quest Diagnostics ( NYSE: DGX ) declares $0.71/share quarterly dividend , 7.6% increase from prior dividend of $0.66. Forward yield 1.91% Payable April 24; for shareholders of record April 10; ex-div April 7. The board of directors has increased the company's share...
Quest Diagnostics Increases Dividend 7.6% To $0.71 Per Quarter; Announces $1 Billion Increase in Share Repurchase Authorization PR Newswire SECAUCUS, N.J. , Feb. 2, 2023 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnosti...
FORTUNE Magazine Names Quest Diagnostics one of 2023 "World's Most Admired Companies" for Ninth Consecutive Year PR Newswire SECAUCUS, N.J. , Feb. 1, 2023 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information servic...
Quest Diagnostics ( NYSE: DGX ) is scheduled to announce Q4 earnings results on Thursday, February 2nd, before market open. The consensus EPS Estimate is $1.90 (-42.9% Y/Y) and the consensus Revenue Estimate is $2.26B (-17.5% Y/Y). Over the last 2 years, DGX has beaten EPS e...
Summary There is a slew of dividend increases coming in February, including from dividend kings Genuine Parts, 3M, and PepsiCo in the first half of the month. Other popular stocks that traditionally announce annual increases in early February are Sherwin-Williams and Cisco. Investor...
Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. Introduction The Dividend Champions list is a m...
News, Short Squeeze, Breakout and More Instantly...
Quest Diagnostics Incorporated Company Name:
DGX Stock Symbol:
NYSE Market:
Quest Diagnostics Incorporated Website:
BALTIMORE, Md. and BASKING RIDGE, N.J., July 18, 2024 (GLOBE NEWSWIRE) -- Haystack Oncology, a Quest Diagnostics (NYSE: DGX) company, and Lisata Therapeutics, Inc. (Nasdaq: LSTA), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors an...
NORTHAMPTON, MA / ACCESSWIRE / July 17, 2024 / Quest Diagnostics Today in the US, millions of women do not have access to quality maternity care during and after pregnancy, which can lead to health risks and complications for mom and baby. The Quest Diagnostics Foundation, as part of the Qu...
Quest Diagnostics to Acquire Outreach Laboratory Services of OhioHealth PR Newswire Goal to broaden access to cost-effective and innovative laboratory services in Ohio SECAUCUS, N.J. and COLUMBUS, Ohio , July 10, 2024 /PRNewswire/ -- Quest Diagnos...